Cargando…

LC-MS based metabolomic profiling for renal cell carcinoma histologic subtypes

Renal cell carcinomas (RCC) are classified according to their histological features. Accurate classification of RCC and comprehensive understanding of their metabolic dysregulation are of critical importance. Here we investigate the use of metabolomic analyses to classify the main RCC subtypes and t...

Descripción completa

Detalles Bibliográficos
Autores principales: Jing, Lun, Guigonis, Jean-Marie, Borchiellini, Delphine, Durand, Matthieu, Pourcher, Thierry, Ambrosetti, Damien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6821699/
https://www.ncbi.nlm.nih.gov/pubmed/31666664
http://dx.doi.org/10.1038/s41598-019-52059-y
_version_ 1783464179241320448
author Jing, Lun
Guigonis, Jean-Marie
Borchiellini, Delphine
Durand, Matthieu
Pourcher, Thierry
Ambrosetti, Damien
author_facet Jing, Lun
Guigonis, Jean-Marie
Borchiellini, Delphine
Durand, Matthieu
Pourcher, Thierry
Ambrosetti, Damien
author_sort Jing, Lun
collection PubMed
description Renal cell carcinomas (RCC) are classified according to their histological features. Accurate classification of RCC and comprehensive understanding of their metabolic dysregulation are of critical importance. Here we investigate the use of metabolomic analyses to classify the main RCC subtypes and to describe the metabolic variation for each subtype. To this end, we performed metabolomic profiling of 65 RCC frozen samples (40 clear cell, 14 papillary and 11 chromophobe) using liquid chromatography-mass spectrometry. OPLS-DA multivariate analysis based on metabolomic data showed clear discrimination of all three main subtypes of RCC (R(2) = 75.0%, Q(2) = 59.7%). The prognostic performance was evaluated using an independent cohort and showed an AUROC of 0.924, 0.991 and 1 for clear cell, papillary and chromophobe RCC, respectively. Further pathway analysis using the 21 top metabolites showed significant differences in amino acid and fatty acid metabolism between three RCC subtypes. In conclusion, this study shows that metabolomic profiling could serve as a tool that is complementary to histology for RCC subtype classification. An overview of metabolic dysregulation in RCC subtypes was established giving new insights into the understanding of their clinical behaviour and for the development of targeted therapeutic strategies.
format Online
Article
Text
id pubmed-6821699
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-68216992019-11-05 LC-MS based metabolomic profiling for renal cell carcinoma histologic subtypes Jing, Lun Guigonis, Jean-Marie Borchiellini, Delphine Durand, Matthieu Pourcher, Thierry Ambrosetti, Damien Sci Rep Article Renal cell carcinomas (RCC) are classified according to their histological features. Accurate classification of RCC and comprehensive understanding of their metabolic dysregulation are of critical importance. Here we investigate the use of metabolomic analyses to classify the main RCC subtypes and to describe the metabolic variation for each subtype. To this end, we performed metabolomic profiling of 65 RCC frozen samples (40 clear cell, 14 papillary and 11 chromophobe) using liquid chromatography-mass spectrometry. OPLS-DA multivariate analysis based on metabolomic data showed clear discrimination of all three main subtypes of RCC (R(2) = 75.0%, Q(2) = 59.7%). The prognostic performance was evaluated using an independent cohort and showed an AUROC of 0.924, 0.991 and 1 for clear cell, papillary and chromophobe RCC, respectively. Further pathway analysis using the 21 top metabolites showed significant differences in amino acid and fatty acid metabolism between three RCC subtypes. In conclusion, this study shows that metabolomic profiling could serve as a tool that is complementary to histology for RCC subtype classification. An overview of metabolic dysregulation in RCC subtypes was established giving new insights into the understanding of their clinical behaviour and for the development of targeted therapeutic strategies. Nature Publishing Group UK 2019-10-30 /pmc/articles/PMC6821699/ /pubmed/31666664 http://dx.doi.org/10.1038/s41598-019-52059-y Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Jing, Lun
Guigonis, Jean-Marie
Borchiellini, Delphine
Durand, Matthieu
Pourcher, Thierry
Ambrosetti, Damien
LC-MS based metabolomic profiling for renal cell carcinoma histologic subtypes
title LC-MS based metabolomic profiling for renal cell carcinoma histologic subtypes
title_full LC-MS based metabolomic profiling for renal cell carcinoma histologic subtypes
title_fullStr LC-MS based metabolomic profiling for renal cell carcinoma histologic subtypes
title_full_unstemmed LC-MS based metabolomic profiling for renal cell carcinoma histologic subtypes
title_short LC-MS based metabolomic profiling for renal cell carcinoma histologic subtypes
title_sort lc-ms based metabolomic profiling for renal cell carcinoma histologic subtypes
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6821699/
https://www.ncbi.nlm.nih.gov/pubmed/31666664
http://dx.doi.org/10.1038/s41598-019-52059-y
work_keys_str_mv AT jinglun lcmsbasedmetabolomicprofilingforrenalcellcarcinomahistologicsubtypes
AT guigonisjeanmarie lcmsbasedmetabolomicprofilingforrenalcellcarcinomahistologicsubtypes
AT borchiellinidelphine lcmsbasedmetabolomicprofilingforrenalcellcarcinomahistologicsubtypes
AT durandmatthieu lcmsbasedmetabolomicprofilingforrenalcellcarcinomahistologicsubtypes
AT pourcherthierry lcmsbasedmetabolomicprofilingforrenalcellcarcinomahistologicsubtypes
AT ambrosettidamien lcmsbasedmetabolomicprofilingforrenalcellcarcinomahistologicsubtypes